Clinical trial
Randomized Double-Blid Placebo Controlled Trial Assessing Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis In Advanced Cirrhosis
NCT00359853 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Double-Blid Placebo Controlled Trial Assessing Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis In Advanced Cirrhosis
- Lead sponsor
- Hospital Clinic of Barcelona
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2000
- Completion date
- March 31, 2005
- Enrollment
- 70
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cirrhosis, hepatorenal syndrome, spontaneous bacterial peritonitis